Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Total Current Liabilities (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Total Current Liabilities data on record, last reported at $23.4 million in Q3 2023.

  • For Q3 2023, Total Current Liabilities fell 13.55% year-over-year to $23.4 million; the TTM value through Sep 2023 reached $23.4 million, down 13.55%, while the annual FY2022 figure was $22.5 million, 91.54% up from the prior year.
  • Total Current Liabilities reached $23.4 million in Q3 2023 per CGEM's latest filing, up from $19.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $62.0 million in Q2 2022 and bottomed at $5.7 million in Q2 2021.
  • Average Total Current Liabilities over 4 years is $20.6 million, with a median of $18.5 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: surged 980.18% in 2022, then crashed 68.28% in 2023.
  • A 4-year view of Total Current Liabilities shows it stood at $14.3 million in 2020, then decreased by 17.97% to $11.7 million in 2021, then surged by 91.54% to $22.5 million in 2022, then grew by 4.2% to $23.4 million in 2023.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $23.4 million in Q3 2023, $19.7 million in Q2 2023, and $26.2 million in Q1 2023.